INmune Bio Dividends and Buybacks

Dividend criteria checks 0/6

INmune Bio does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-25.7%

Buyback Yield

Total Shareholder Yield-25.7%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?

Nov 03
Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?

INmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On Goal

Sep 30

It's Unlikely That Shareholders Will Increase INmune Bio, Inc.'s (NASDAQ:INMB) Compensation By Much This Year

Jul 12
It's Unlikely That Shareholders Will Increase INmune Bio, Inc.'s (NASDAQ:INMB) Compensation By Much This Year

Is INmune Bio (NASDAQ:INMB) Using Debt Sensibly?

Jan 19
Is INmune Bio (NASDAQ:INMB) Using Debt Sensibly?

Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?

Sep 04
Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way?

Is INmune Bio (NASDAQ:INMB) Using Too Much Debt?

May 12
Is INmune Bio (NASDAQ:INMB) Using Too Much Debt?

Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money

Jan 16
Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money

Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money

Jul 11
Here's Why INmune Bio (NASDAQ:INMB) Can Manage Its Debt Despite Losing Money

INmune Bio: Possibly The Once In A Lifetime Dip

May 25

INmune Bio: Speculative Biotech With 2 Solid Potential Approaches To Treating AD And Solid Tumors

Apr 05

Is INmune Bio (NASDAQ:INMB) A Risky Investment?

Mar 25
Is INmune Bio (NASDAQ:INMB) A Risky Investment?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if INMB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if INMB's dividend payments have been increasing.


Dividend Yield vs Market

INmune Bio Dividend Yield vs Market
How does INMB dividend yield compare to the market?
SegmentDividend Yield
Company (INMB)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.2%
Industry Average (Biotechs)2.3%
Analyst forecast (INMB) (up to 3 years)n/a

Notable Dividend: Unable to evaluate INMB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate INMB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate INMB's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as INMB has not reported any payouts.


Discover strong dividend paying companies